GLUT4 Enhancer Factor (GEF) Interacts with MEF2A and HDAC5 to Regulate the GLUT4 Promoter in Adipocytes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The insulin-responsive glucose transporter, GLUT4, is regulated in various physiologic states at the transcriptional level. When expressed in transgenic mice, the human GLUT4 promoter is governed by two cis-acting sequences: an MEF2 binding domain and Domain I, that function both as positive and negative regulators depending on the physiologic state. MEF2 proteins and GLUT4 enhancer factor (GEF) are known ligands for these cis-acting elements, but their mechanism of action is unclear. To begin to understand this important process, we have characterized GEF structural domains and its interactions with the MEF2A isoform. We find that the C terminus of GEF comprises its DNA-binding domain, but does not contribute to GEF homo-oligomerization. We also have found that GEF dimerizes with increased affinity to a hypophosphorylated form of MEF2A. Furthermore, we demonstrated that MEF2A binding to its cognate binding site can increase the DNA binding activity of GEF to Domain I, suggesting a novel mechanism for MEF2A transcriptional activation. Finally, we have demonstrated that the transcriptional co-repressor HDAC5 can interact with GEF in the absence of MEF2 proteins and specifically inhibit GLUT4 promoter activity. These findings lead to the hypothesis that GEF and the MEF2 proteins form a complex on the GLUT4 promoter that allows for recruitment of transcriptional co-regulators (repressors and/or activators) to control GLUT4 promoter activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Further, TFAM overexpression results in an increase GLUT4 (a key regulator of glucose transport) expression, which is directly regulated by MEF2A (36).”
From TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle (2019) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“TFAM overexpression increased AMPK activity in conjunction with MEF2A expression that likely contributed to increased GLUT4 expression (36) (Figs. 4E and 6B).”
From TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle (2019) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TRANSCRIPTIONAL CONTROL OF MUSCLE DEVELOPMENT BY MYOCYTE ENHANCER FACTOR-2 (MEF2) PROTEINS
Black, B. L., & Olson, E. N. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.167 · Cited by 1,039
Lu, J., McKinsey, T. A., Zhang, C.-L., & Olson, E. N. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00025-3 · Cited by 547
Lu, J., McKinsey, T. A., Nicol, R. L., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080064097 · Cited by 518
Histone deacetylase degradation andMEF2 activation promote the formation of slow-twitch myofibers
Potthoff, M. J., Wu, H., Arnold, M. A., Shelton, J. M., Backs, J., McAnally, J., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31960 · Cited by 424
Czubryt, M. P., McAnally, J., Fishman, G. I., & Olson, E. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337639100 · Cited by 418
Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting
Berger, J., Biswas, C., Vicario, P. P., Strout, H. V., Saperstein, R., & Pilch, P. F. (1989) · Nature · doi:10.1038/340070a0 · Cited by 299
Regulation of glucose transporter messenger RNA in insulin-deficient states
Sivitz, W. I., DeSautel, S. L., Kayano, T., Bell, G. I., & Pessin, J. E. (1989) · Nature · doi:10.1038/340072a0 · Cited by 239
Garvey, W. T., Huecksteadt, T. P., & Birnbaum, M. J. (1989) · Science · doi:10.1126/science.2662408 · Cited by 230
Gibbs, E. M., Stock, J. L., McCoid, S. C., Stukenbrok, H. A., Pessin, J. E., Stevenson, R. W., Milici, A. J., & McNeish, J. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117823 · Cited by 226
Ziel, F. H., Venkatesan, N., & Davidson, M. B. (1988) · Diabetes · doi:10.2337/diab.37.7.885 · Cited by 215
Research works printed but not linked: 2
- 14. Holmes, B. F., Lang, D. B., Birnbaum, M. J., Mu, J., and Dohm, G. L. (2004) Am. J. Physiol. 287, E739-E743
- 16. Sparling, D. P., Griesel, B. A., and Olson, A. L. (2007) Am. J. Physiol. 292, E1149-E1156
Cited by
BOARD-INVITED REVIEW: The biology and regulation of preadipocytes and adipocytes in meat animals1,2
Hausman, G. J., Dodson, M. V., Ajuwon, K., Azain, M., Barnes, K. M., Guan, L. L., Jiang, Z., Poulos, S. P., Sainz, R. D., Smith, S., et al. (2009) · Journal of Animal Science · doi:10.2527/jas.2008-1427 · Cited by 342
“…Hassan et al., 2007), adiponectin gene expression (Kim et al., 2006), glucose uptake [GLUT-4 (Fernyhough et al., 2007), and GLUT-4 enhancer factor (Sparling et al., 2008)], glucose and lipid metabolism with AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide ribonucleoside…”
Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus
Christensen, D. P., Dahllöf, M., Lundh, M., Rasmussen, D. N., Nielsen, M. D., Billestrup, N., Grunnet, L. G., & Mandrup-Poulsen, T. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00021 · Cited by 261
Loss of ACE2 Exaggerates High-Calorie Diet–Induced Insulin Resistance by Reduction of GLUT4 in Mice
Takeda, M., Yamamoto, K., Takemura, Y., Takeshita, H., Hongyo, K., Kawai, T., Hanasaki-Yamamoto, H., Oguro, R., Takami, Y., Tatara, Y., et al. (2013) · Diabetes · doi:10.2337/db12-0177 · Cited by 110
“We could not detect MEF2A protein in the adipose tissue, but it has been reported that low levels of MEF2A can regulate the expression of GLUT4 in adipose tissue (21,22).”
BackgroundHistone deacetylases in cardiovascular and metabolic diseases
Bagchi, R. A., & Weeks, K. L. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.04.003 · Cited by 112
Paul, M. R., Pan, T.-C., Pant, D. K., Shih, N. N. C., Chen, Y., Harvey, K. L., Solomon, A. C., Lieberman, D. B., Morrissette, J. J. D., Soucier-Ernst, D., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129941 · Cited by 125
“SLC2A4RG is a transcriptional activator of the glucose transporter SLC2A4 (GLUT4) (23).”
Flores-Opazo, M., McGee, S. L., & Hargreaves, M. (2020) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000224 · Cited by 102
“In addition to GEF and MEF2 regulation of adipose tissue GLUT4 expression (150), the liver X receptor α appears to have a role in GLUT4 expression (151), although to our knowledge, exercise effects on these factors have not been studied.”
BackgroundKhan, S., & Jena, G. (2015) · Epigenomics · doi:10.2217/epi.15.20 · Cited by 102
Regulation of GLUT4 and Insulin-Dependent Glucose Flux
Olson, A. L. (2012) · ISRN Molecular Biology · doi:10.5402/2012/856987 · Cited by 123
“Instead, differentiation-dependent GLUT4 gene expression is regulated by the release of class II histone deactyleases (HDACs) that bind to the transactivating factors [132, 133].”
BackgroundSelf-citationKoh, J.-H., Johnson, M. L., Dasari, S., LeBrasseur, N. K., Vuckovic, I., Henderson, G. C., Cooper, S. A., Manjunatha, S., Ruegsegger, G. N., Shulman, G. I., et al. (2019) · Diabetes · doi:10.2337/db19-0088 · Cited by 92
“Further, TFAM overexpression results in an increase GLUT4 (a key regulator of glucose transport) expression, which is directly regulated by MEF2A (36).”
BackgroundEndurance Exercise Improves Molecular Pathways of Aerobic Metabolism in Patients With Myositis
Munters, L. A., Loell, I., Ossipova, E., Raouf, J., Dastmalchi, M., Lindroos, E., Chen, Y., Esbjörnsson, M., Korotkova, M., Alexanderson, H., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39624 · Cited by 95
“Additionally, histone deacetylase 5 (HDAC-5) can act as an inhibitor of insulin-dependent glucose transporter 4 promoter (47), and a decrease of HDAC-5 could indicate a more balanced glucose transport.”
BackgroundJensen, T. E., Wojtaszewski, J. F. P., & Richter, E. A. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01979.x · Cited by 79
“In addition, both MEF and GEF have been shown in 3T3-L1 adipocytes to interact with HDAC5, another AMPK target which, upon phosphorylation on Ser259 and Ser498, binds 14-3-3 proteins and is exported from the nucleus (McGee et al. 2008b, Sparling et al. 2008).”
BackgroundThe role of CaMKII in regulating GLUT4 expression in skeletal muscle
Ojuka, E. O., Goyaram, V., & Smith, J. A. H. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00091.2012 · Cited by 89
Lehnen, A. M., Leguisamo, N. M., Pinto, G. H., Markoski, M. M., Angelis, K. D., Machado, U. F., & Schaan, B. D. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-67 · Cited by 67
“In addition, AMPK can phosphorylate HDAC5 protein, which is then separated from the enhancer, thus favoring GLUT4 expression [29].”
BackgroundUnderstanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases
Asif, S., Morrow, N. M., Mulvihill, E. E., & Kim, K.-H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.590369 · Cited by 78
Weems, J. C., Griesel, B. A., & Olson, A. L. (2012) · Diabetes · doi:10.2337/db11-0737 · Cited by 63
“The -895-hGLUT4-luc reporter was activated by cotransfection with MEF2A and GEF and treated without or with 25 mmol/L forskolin for the duration of the transfection period to ensure that cAMP was elevated while transcription of the reporter construct was occurring.”
BackgroundMethodInfluentialSelf-citationSelective class IIa HDAC inhibitors: myth or reality
Giorgio, E. D., Gagliostro, E., & Brancolini, C. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1727-8 · Cited by 68
“Certainly anti-cancer therapy is the first and most important scope, however, the involvement of class IIa HDACs in the regulation of Glut4 [94, 95, 96, 97], NF-kB”
BackgroundEpigenetic changes in diabetes
Al-Haddad, R., Karnib, N., Assaad, R. A., Bilen, Y., Emmanuel, N., Ghanem, A., Younes, J., Zibara, V., Stephan, J. S., & Sleiman, S. F. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.046 · Cited by 58
Class II Histone Deacetylases Limit GLUT4 Gene Expression during Adipocyte Differentiation
Weems, J. C., & Olson, A. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.157107 · Cited by 57
Self-citationKonno, T., Chen, D., Wang, L., Wakimoto, H., Teekakirikul, P., Nayor, M. G., Kawana, M., Eminaga, S., Gorham, J., Pandya, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012826107 · Cited by 58
“Increased transcription of Mef2a could provide metabolic compensation for these intrinsic stresses by regulating mitochondrial biogenesis (15), regulating the insulin-responsive glucose transporter type 4 (30), and activating genes that enable myocytes to use glucose instead of fatty acids for energy production (12, 1…”
BackgroundMurgia, M., Jensen, T. E., Cusinato, M., Garcia, M., Richter, E. A., & Schiaffino, S. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.174888 · Cited by 51
“GEF and MEF2A appear to form a complex on the GLUT4 promoter that allows for recruitment of transcriptional co-regulators, including HDAC5, to control GLUT4 promoter activity (Knight et al. 2003; Sparling et al. 2008).”
BackgroundBalasubramanian, R., Robaye, B., Boeynaems, J., & Jacobson, K. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116203 · Cited by 47
“A role for the regulation of GLUT4 expression by HDAC in both skeletal muscle cells and mature adipocytes has been reported previously [22, 27–30].”
BackgroundNovotny, G. W., Lundh, M., Backe, M. B., Christensen, D. P., Hansen, J. B., Dahllöf, M. S., Pallesen, E. M. H., & Mandrup-Poulsen, T. R. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.09.014 · Cited by 40
Insulin Regulates Fusion of GLUT4 Vesicles Independent of Exo70-mediated Tethering
Lizunov, V. A., Lisinski, I., Stenkula, K. G., Zimmerberg, J. J., & Cushman, S. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806460200 · Cited by 44
Griesel, B. A., Weems, J. C., Russell, R. A., Abel, E. D., Humphries, K. M., & Olson, A. L. (2010) · Diabetes · doi:10.2337/db09-1542 · Cited by 39
“Luciferase assays were performed as previously described with plasmids encoding LXR- , myocyte enhancer factor (MEF)-2A, and GLUT4 enhancer factor (GEF) 24 h after transfection (21).”
MethodSelf-citationHu, H., Li, L., Wang, C., He, H., Mao, K., Ma, X., Shi, R., Oh, Y., Zhang, F., Lü, Y., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000362967 · Cited by 33
Tessneer, K. L., Jackson, R. M., Griesel, B. A., & Olson, A. L. (2014) · Endocrinology · doi:10.1210/en.2013-2148 · Cited by 36
Self-citationKain, V., Kapadia, B. B., Viswakarma, N., Seshadri, S., Prajapati, B., Jena, P. K., Meda, C. L. T., Subramanian, M., Suraj, S. K., Kumar, S. T., et al. (2015) · Scientific Reports · doi:10.1038/srep15197 · Cited by 33
Epigenetic Regulation of Glucose Transporters in Non-Small Cell Lung Cancer
O'Byrne, K. J., Baird, A., Kilmartin, L., Leonard, J., Sacevich, C., & Gray, S. G. (2011) · Cancers · doi:10.3390/cancers3021550 · Cited by 37
Dhaouadi, N., Li, J., Feugier, P., Gustin, M., Dab, H., Kacem, K., Bricca, G., & Cerutti, C. (2014) · Genomics · doi:10.1016/j.ygeno.2014.05.001 · Cited by 36
“SLC2A4RG is implicated in the expression of the glucose transporter 4 (GLUT4) [73], whose expression is regulated by hypoxia [74].”
BackgroundMoraes, P. A., Yonamine, C. Y., Junior, D. C. P., Esteves, J. V. D. C., Machado, U. F., & Mori, R. C. T. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.07.040 · Cited by 27
Liu, B., Ou, W., Fang, L., Tian, C., & Xiong, Y. (2022) · Aging and Disease · doi:10.14336/ad.2022.0825 · Cited by 28
“In primary dispersed adipocytes, hyper-phosphorylation of MEF2A can enhance its binding to MEF2D, thus reducing its binding to the GLUT4 promoter and resulting in down-regulation of GLUT4 [114, 151].”
BackgroundInfluentialMicroRNA-16 modulates macrophage polarization leading to improved insulin sensitivity in myoblasts
Talari, M., Kapadia, B. B., Kain, V., Seshadri, S., Prajapati, B., Rajput, P., Misra, P., & Parsa, K. V. L. (2015) · Biochimie · doi:10.1016/j.biochi.2015.10.004 · Cited by 29
Wu, X., Xiao, C., Han, Z., Zhang, L., Zhao, X., Hao, Y., Xiao, J., Gallagher, C. S., Kraft, P. L., Morton, C. C., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.05.015 · Cited by 24
Transcription Factor GATA-6 Recruits PPARα to Cooperatively Activate Glut4 Gene Expression
Yao, C.-X., Xiong, C.-J., Wang, W., Yang, F., Zhang, S., Wang, T., Wang, S., Yu, H., Wei, Z., & Zang, M. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.11.011 · Cited by 19
Lehnen, A. M. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s10-002 · Cited by 24
“On the other hand, AMPK protein activation through muscle contraction requires HDAC5 phosphorylation resulting in MEF2 release [93].”
BackgroundThe Role of the C-Clamp in Wnt-Related Colorectal Cancers
Ravindranath, A. J., & Cadigan, K. M. (2016) · Cancers · doi:10.3390/cancers8080074 · Cited by 18
“HDBP1 is also known as SLC2A4 regulator (SLC2A4RG) or GLUT4 enhancer factor (GLUT4EF) [69,70], and have been linked to increased risk of intestinal disorders [71,72].”
BackgroundGRK5 promoted renal fibrosis via HDAC5 /Smad3 signaling pathway
Xiang, H., Huang, J., Song, A., Liu, F., Xiong, J., & Zhang, C. (2024) · The FASEB Journal · doi:10.1096/fj.202301595rrr · Cited by 9
“21,30 MEF2A is critical for the transcription regulation of Smad7 expression.”
BackgroundThe Potential of Epigenetic Compounds in Treating Diabetes
Gray, S. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00017-0 · Cited by 3
miR-92a-1-5p targets MEF2A to induce insulin resistance in myocardial ischemia/reperfusion injury
Zhou, A.-Q., Cao, Y., Song, Y., Zhang, B.-F., Chen, K., Yang, S.-Y., & Chen, H. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151938 · Cited by 2
The Potential of Epigenetic Compounds in Treating Diabetes
Gray, S. G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-388415-2.00017-2 · Cited by 7
The histone deacetylase family in health and disease
Wen, R., Yang, Y., Zhang, T., Zhang, S.-Y., Yang, X.-R., Zhang, L.-Y., Hao, P.-H., Zheng, Y., Ni, Y., & Zhang, T. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02764-8 · Cited by 2
Joseph, J. S., & Fagbohun, O. F. (2022) · Comparative Clinical Pathology · doi:10.1007/s00580-022-03318-4 · Cited by 2
“GLUT4 is an insulin-responsive glucose transporter that controls glucose uptake (Charron et al. 1999; Sparling et al. 2008).”
BackgroundInsulin Signaling, Epigenetics, and Human Diseases
Chruvattil, R., Belani, M., Patel, T. P., & Gupta, S. S. (2017) · Wiley eBooks · doi:10.1002/9783527697274.ch18 · Cited by 1
Stöckli, J., & James, D. E. (2009) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a001046.01 · Cited by 1
Glucose Transport in White Adipocyte
Cormont, M., & Kaddai, V. (2012) · Springer eBooks · doi:10.1007/978-2-8178-0343-2_7 · Cited by 2
Le transport du glucose dans l’adipocyte blanc
Cormont, M., & Kaddai, V. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0332-6_7 · Cited by 1
Ojuka, E. O., Goyaram, V., & Smith, J. A. H. (2012)
Lima, G. A. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2011.tde-23012012-165455
Kalhor, H., Peeri, M., Matinhomaee, H., & Izadi, M. (2017) · DOAJ (DOAJ: Directory of Open Access Journals)
Exercise and adipose tissue GLUT4
Opazo, F., & Alejandro, M. (2017) · Minerva Access (University of Melbourne)
Lehnen, A. M., Pinto, G. H., Borges, J., Markoski, M. M., & Schaan, B. D. (2020) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2019-0337
Epigenetic modifications and regulations in gastrointestinal diseases
Bhattacharya, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823931-5.00005-0 · Cited by 1
The role of the circadian transcription factor KLF10 in liver physiology
Ruberto, A. A. (2019) · theses.fr (ABES) · doi:10.70675/cb3492c2z5778z48e3za7d7zf17279fd718b
Metadata
- Authors
- Sparling, D. P., Griesel, B. A., Weems, J., & Olson, A. L.
- Affiliations
- University of Oklahoma Health Sciences Center (US)
- Corresponding author
- Olson, Ann Louise
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 283
- Issue
- 12
- Pages
- 7429-7437
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2276327
- OpenAlex
- W1985221423
- Cited by
- 53
- References
- 28
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2020: 4 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 6 · 2013: 2 · 2012: 8
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4613 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 062341, R01DK062341)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- MEF2A, HDAC5, adipocytes, transcriptional regulation, cis-regulatory elements, protein-protein interaction, DNA-binding domain, corepressors, glucose transporters, insulin signaling
- MeSH terms
- Animals, Chlorocebus aethiops, DNA-Binding Proteins, Histone Deacetylases, Mice, Transgenic, Phosphorylation, Promoter Regions, Genetic, Protein Binding, Transcription Factors, Adipocytes, Myogenic Regulatory Factors, Dimerization, COS Cells, Protein Isoforms, Glucose Transporter Type 4, Mice, MEF2 Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.